KIORA PHARMACEUTICALS INC (KPRX) Current Reports & Earnings Releases
Upcoming
- 2026-11-06 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-19 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-08-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-18 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-11 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-07 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-04-02 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-03-25 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-08-13 | 8-K | Reg FD Disclosure | SEC |
| 2025-08-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-04 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-06-03 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-05-09 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-25 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-01-15 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-11-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-29 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-08-09 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-07-30 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-07-01 | 8-K | Officer / Director Changes, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-06-07 | 8-K | Item 3.03, Charter Amendments, Other Events, Financial Statements & Exhibits | SEC |
| 2024-05-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-05-03 | 8-K | Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-03-25 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-12 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-02-01 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-01-31 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-01-16 | 8-K | Listing Notice | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.